The resolution urges the New Jersey Department of Health (DOH) to enhance public awareness regarding the dangers associated with xylazine, a non-opioid veterinary tranquilizer that has emerged as a concerning street drug, commonly referred to as Tranq or the Zombie Drug. Xylazine is not approved for human use and has been linked to a rising number of overdose deaths in New Jersey and neighboring states. As a central nervous system depressant, it can lead to severe health issues, including drowsiness, amnesia, and dangerously low levels of breathing, heart rate, and blood pressure. The resolution highlights the alarming trend of xylazine being used in combination with other drugs, particularly illicit fentanyl, which exacerbates the risk of life-threatening overdoses.

The resolution calls for the DOH to take proactive measures to educate the public about the risks of xylazine use, as traditional overdose treatments like naloxone are ineffective against this drug. It emphasizes the need for appropriate educational resources to inform New Jerseyans about the potential dangers of xylazine, especially given its association with various other substances that contribute to overdose fatalities. The resolution reflects a growing public health threat posed by xylazine and the urgent need for increased awareness and preventive measures.